In a Danish study, patients with chronic lymphocytic leukemia (CLL) showed a higher risk for skin cancer, metastasis, and death than matched individuals at 10 years. Researchers conducted a population ...
In "Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels continue their conversation on communicating ...
Most patients initiated full-dose ibrutinib, while reduced starting doses clustered in older, more comorbid, poorer ECOG cohorts, indicating clinician-driven personalization rather than cardiovascular ...
Four zanubrutinib trials in R/R CLL/SLL were pooled using random-effects modeling, with heterogeneous designs (including open-label and single-arm cohorts) and variable AE reporting. Overall ...
In collaboration with researchers in South Korea, a team from The Hospital for Sick Children (SickKids) has discovered a promising therapeutic target in fat tissue that improves cellular function, ...
There are two types of inflammation: acute and chronic. Acute inflammation is the kind that lasts a few hours, days, or weeks, and it’s helpful to healing. It’s your immune system’s response when ...
Some women with complex chronic illnesses are using chatbots to search for diagnoses or relief from their symptoms. By Maggie Astor When Margie Smith got sick in 2022, she sought help from a parade of ...
A key cancer-fighting gene in leukemia is switched off—not broken—and scientists from The Jackson Laboratory (JAX) have found a way to switch it back on. In a study published in Science Translational ...
SPIRIT-HF, another spironolactone trial in HFpEF; the ESSENCE imaging study of the drug olezarsen; the SirPAD trial in peripheral artery disease; and ultrasound-guided femoral venous access are the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results